Compare Sumber Energi Andalan Tbk (ITMA) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sumber Energi Andalan Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Sumber Energi Andalan Tbk trades at Rp1,315 (market cap 1.33T, 22.7K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 8.5× Sumber Energi Andalan Tbk's market cap, and Tempo Scan Pacific Tbk. is more actively traded (1.77M versus 22.7K). Which is the better fit depends on your goals.
| ITMA | TSPC | |
|---|---|---|
Market Cap | 1.33T | 11.36T |
Volume | 22.7K | 1.77M |
Lot | 227 | 17.71K |
Turnover | 30.08M | 4.61B |
Average Price | 1,325.15 | 2,603.9 |
Value | 30.08M | 4.61B |
Indicative Equilibrium Price | — | 2,590 |
Indicative Equilibrium Volume | — | 300 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sumber Energi Andalan Tbk
PT Sumber Energi Andalan Tbk (the Company) was established based on Notarial deed No. 6 dated September 21, 2011 of Leolin Jayayanti, S.H., notary in Jakarta. PT Sumber Energi Andalan Tbk manufactures gold jewelry such as necklaces, bracelets, rings, and pendants. The company has a factory located on a site of 18.3 Ha in the industrial estate Rungkut, Surabaya. Previously the Company's name had been changed from PT Itamaraya Gold Industry Tbk to PT Itamaraya Tbk.
Read more on ITMA →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
